These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

312 related articles for article (PubMed ID: 8386397)

  • 1. [Evaluation of a drug withdrawal unit].
    Stohler R; Petitjean S; Ladewig D
    Ther Umsch; 1993 Mar; 50(3):160-8. PubMed ID: 8386397
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Withdrawal treatment of drug dependent patients with the aim of achieving abstinence].
    Stohler R; Petitjean S; Hörler C; Bardeleben U; Ladewig D
    Psychiatr Prax; 1994 Jan; 21(1):10-2. PubMed ID: 8146238
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Is premature termination of opiate detoxification due to intensive withdrawal or craving?].
    Scherbaum N; Heppekausen K; Rist F
    Fortschr Neurol Psychiatr; 2004 Jan; 72(1):14-20. PubMed ID: 14745685
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Subjective wellbeing and somatic markers in methadone substitution. Evaluation of 61 heroin addicts].
    Giacomuzzi SM; Riemer Y; Kemmler G; Ertl M; Richter R; Rössler H; Hinterhuber H
    Fortschr Med Orig; 2001 Nov; 119(3-4):103-8. PubMed ID: 11789120
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Naltrexone in the treatment of opiate dependence.
    Resnick RB; Washton AM; Thomas MA; Kestenbaum RS
    NIDA Res Monogr; 1978; (19):321-32. PubMed ID: 218108
    [No Abstract]   [Full Text] [Related]  

  • 6. The effectiveness of drug treatment.
    Gerstein DR
    Res Publ Assoc Res Nerv Ment Dis; 1992; 70():253-82. PubMed ID: 1311121
    [No Abstract]   [Full Text] [Related]  

  • 7. Psychosis in the opioid addicted patient: assessment and treatment.
    Uhde TW; Redmond DE; Kleber HD
    J Clin Psychiatry; 1982 Jun; 43(6):240-7. PubMed ID: 7085579
    [No Abstract]   [Full Text] [Related]  

  • 8. Multimodal drug addiction treatment: a field comparison of methadone and buprenorphine among heroin- and cocaine-dependent patients.
    Vigezzi P; Guglielmino L; Marzorati P; Silenzio R; De Chiara M; Corrado F; Cocchi L; Cozzolino E
    J Subst Abuse Treat; 2006 Jul; 31(1):3-7. PubMed ID: 16814005
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The heroin addict on the rehabilitation ward.
    Schiller C; Richter RW
    Arch Phys Med Rehabil; 1974 Sep; 55(9):431-2. PubMed ID: 4416292
    [No Abstract]   [Full Text] [Related]  

  • 10. [Pain, anesthesia and drug addiction].
    Carpentier M
    Rev Stomatol Chir Maxillofac; 1997 Aug; 98(2):120-2. PubMed ID: 9324730
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reductions in criminal convictions after addiction treatment: 5-year follow-up.
    Gossop M; Trakada K; Stewart D; Witton J
    Drug Alcohol Depend; 2005 Sep; 79(3):295-302. PubMed ID: 16102373
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Methadone doses of 100 mg or greater are more effective than lower doses at suppressing heroin self-administration in opioid-dependent volunteers.
    Donny EC; Brasser SM; Bigelow GE; Stitzer ML; Walsh SL
    Addiction; 2005 Oct; 100(10):1496-509. PubMed ID: 16185211
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The emergence of maternal drug addiction as a problem in Ireland 1981.
    Ryan A; Magee T; Johnson SS; Griffin E; Kelly MG
    Ir Med J; 1983 Feb; 76(2):86-9. PubMed ID: 6841026
    [No Abstract]   [Full Text] [Related]  

  • 14. [Use of presynaptic alpha-mimetics for withdrawal in heroin addicts].
    Gorceix A; Dugarin J; Pommier F
    Ann Med Interne (Paris); 1985; 136(5):389-92. PubMed ID: 2865924
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Over- and underreporting of recent drug use in subjects entering an inpatient detoxification unit.
    Zullino DF; Krenz S; Eap CB; Benguettat D; Khan R
    Eur J Med Res; 2008 Jan; 13(1):15-20. PubMed ID: 18226992
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Drug withdrawal in newborns - clinical data of 49 infants with intrauterine drug exposure: what should be done?].
    Bläser A; Pulzer F; Knüpfer M; Robel-Tillig E; Vogtmann C; Nickel P; Kiess W
    Klin Padiatr; 2008; 220(5):308-15. PubMed ID: 18260044
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Prospective study of favorable factors in follow-up of drug addicted patients--apropos of 257 patients of the Cassini Center in Paris].
    Goeb JL; Coste J; Bigot T; Ferrand I
    Encephale; 2000; 26(6):11-20. PubMed ID: 11217533
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The treatment of dependence in the therapeutic community].
    Roussaux JP; Ledoux Y; Snoy T; Simonart C; Pelc I
    Acta Psychiatr Belg; 1990; 90(5-6):259-77. PubMed ID: 1670403
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Substance use and quality of life over 12 months among buprenorphine maintenance-treated and methadone maintenance-treated heroin-addicted patients.
    Maremmani I; Pani PP; Pacini M; Perugi G
    J Subst Abuse Treat; 2007 Jul; 33(1):91-8. PubMed ID: 17588494
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influence of the dose on the severity of opiate withdrawal symptoms during methadone detoxification.
    Glasper A; Gossop M; de Wet C; Reed L; Bearn J
    Pharmacology; 2008; 81(2):92-6. PubMed ID: 17952010
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.